Autism Centers of Excellence R01
ID: 360643Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360643
Timeline
    Description

    The National Institutes of Health (NIH) is offering a grant opportunity titled "Autism Centers of Excellence R01," aimed at advancing research on autism through collaborative multi-site projects. This initiative seeks applications that leverage innovative technologies and methodologies to build upon 23 years of progress in autism research, with a focus on forming meaningful collaborations among various scientific disciplines. The estimated total program funding is $10 million, with three awards expected, and interested applicants are encouraged to prepare their proposals ahead of the anticipated application opening, which is expected to occur after July 1, 2026. For further inquiries, potential applicants can contact Dr. Alice Kau at Kaua@mail.nih.gov or by phone at 301-496-1385.

    Point(s) of Contact
    Alice Kau, Ph.D.
    (301) 496-1385
    Kaua@mail.nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Autism Centers of Excellence P50
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Autism Centers of Excellence P50," aimed at soliciting research applications that build on two decades of progress in autism research. This initiative encourages collaborative investigations that leverage cutting-edge technologies and methodologies to advance understanding in this critical area of health. With an estimated total program funding of $10 million and the expectation of awarding three grants, interested applicants are advised to prepare their proposals ahead of the anticipated application period, which is expected to open in July 2026, with a closing date in November 2026. For further inquiries, potential applicants can contact Dr. Alice Kau at Kaua@mail.nih.gov or by phone at 301-496-1385.
    Biomarkers of Cognitive Decline and Dementias of Aging in Individuals within the Autism Spectrum
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) aimed at supporting observational studies focused on biomarkers of cognitive decline and dementias of aging in individuals on the Autism Spectrum. The primary objective of this initiative is to investigate age-related neurodegeneration within the Autism Spectrum Disorders (ASD) population, characterize the physiopathology of Alzheimer's disease and related dementias, and develop precision-medicine strategies tailored to this unique group. This funding opportunity encourages collaborations between researchers specializing in autism and those with expertise in aging and dementia, fostering interdisciplinary approaches to address this critical area of health research. Interested applicants can reach out to Dr. Alessandra Rovescalli at rovescaa@mail.nih.gov or by phone at 301-215-0335 for further information, with the estimated synopsis posting date set for December 1, 2025, and applications expected to be solicited by February 5, 2026.
    Notice of Intent to Publish a Notice of Funding Opportunity for Biomarkers of Cognitive Decline and Dementias of Aging in Individuals within the Autism Spectrum (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at advancing research on biomarkers of cognitive decline and dementias in individuals on the Autism Spectrum. This initiative seeks to conduct observational studies utilizing deep phenotyping techniques, including neuroimaging and molecular approaches, to identify and characterize neurodegeneration biomarkers in this population, as well as to evaluate existing dementia biomarkers in the context of Autism Spectrum Disorders (ASD). The total estimated funding for this program is $5 million, with the NOFO expected to be published in December 2024 and applications due by February 2025, leading to awards anticipated by September 2025. Interested applicants are encouraged to prepare collaborative proposals in advance of the official announcement.
    Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan." This initiative aims to gather unique data to enhance understanding of the resources and opportunities necessary to improve outcomes for individuals with autism and Fragile X Syndrome (FXS) throughout their lives. The program consists of three components: data collection on autistic teens and young adults, data collection on individuals with FXS, and dissemination of public health products to support these populations. The total estimated funding for this program is $18 million, with 11 awards expected to be made. Interested applicants can reach out to Seema Gupta at (770) 488-6527 or via email at cvk9@cdc.gov for further information. Applications must be submitted electronically by January 30, 2026, with the project anticipated to start on July 1, 2026.
    Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the funding opportunity titled "Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)," aimed at advancing research on the biological mechanisms underlying complex brain disorders such as schizophrenia, bipolar disorder, and autism. This initiative encourages studies that explore high-confidence risk factors associated with these disorders, focusing on intracellular, transcellular, and circuit mechanisms, while emphasizing the importance of disseminating findings to enhance data resources and therapeutic target identification. Eligible applicants include a wide range of institutions, including historically black colleges, tribal colleges, and various nonprofit organizations, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and detailed information can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-024.html.
    INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the INCLUDE Project: Transformative Research Awards for Down syndrome, aimed at advancing innovative research to improve health and quality of life for individuals with Down syndrome. This funding opportunity invites applications for groundbreaking research that can establish new scientific paradigms or develop transformative technologies related to Down syndrome and its co-occurring conditions, with no preliminary data required. The program has an estimated total funding of $3 million, with individual awards ranging from $250,000 to $500,000, and is expected to support approximately four projects. Interested applicants can reach out to Dr. Charlene Schramm at schrammc@nih.gov or by phone at 301-402-3793, with applications due by February 19, 2026, and anticipated awards announced by September 1, 2026.
    INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome, aimed at enhancing health and quality of life for individuals with Down syndrome. This funding opportunity invites researchers to propose innovative exploratory and developmental projects that address critical needs identified in the INCLUDE Project objectives, potentially leading to breakthroughs in biomedical, behavioral, or clinical research. The total estimated program funding is $1 million, with individual awards ranging from $50,000 to $200,000, and the application process is open to a diverse range of eligible applicants, including tribal governments and community-based organizations. Interested parties should contact Dr. Melissa Parisi at 301-728-1861 or via email at parisima@mail.nih.gov for further information, with applications due by February 19, 2026, and awards expected to be announced by September 1, 2026.
    NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce the NIH Director’s Transformative Research Awards, a federal grant opportunity aimed at supporting innovative and unconventional research projects. This program encourages individual scientists or collaborative teams to propose groundbreaking research that has the potential to redefine scientific paradigms or develop transformative technologies, without the need for preliminary data or detailed experimental plans. With an estimated total funding of $8 million and the expectation of awarding seven grants, interested applicants should prepare their proposals in advance, as applications will be solicited starting June 20, 2025, with a closing date of September 3, 2025. For further inquiries, potential applicants can contact Dr. Patricia Labosky at TransformativeAwards@mail.nih.gov or by phone at 301-594-4863.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns," aimed at advancing research in novel screening methods and therapeutic interventions for genetic conditions identified through newborn screening. This initiative encourages the development of innovative screening assays, the use of artificial intelligence, and the exploration of socio-economic implications related to newborn screening, with a focus on conditions that may benefit from early detection and treatment. The grant supports long-term research projects (R01) and is open to a diverse range of applicants, including higher education institutions and community-based organizations, with applications accepted until November 16, 2027. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-265.html.
    Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for collaborative research projects focused on type 1 diabetes, specifically utilizing biosamples and data from established clinical studies. The objective is to advance the understanding of the disease's etiology and pathogenesis, with funding available for studies that aim to explore disease mechanisms, delay onset, and improve prevention strategies. A total of $5.5 million is committed for up to four awards in Fiscal Years 2026 and 2027, with application deadlines beginning on May 26, 2025, and a final submission date of March 9, 2026. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.